The Irish Medicines Board (IMB) suspended the marketing and use of Acomplia in Ireland on 23rd October 2008 following a recommendation issued by the European Medicines Agency (EMEA) on the same date. This national action was taken following review of the product by the EMEA’s Committee for Medicinal Products for Human Use (CHMP) who concluded [...]
Significant blood pressure reductions is obtained in difficult-to-treat, black patients receiving Exforge-based therapy. New multinational data show that black patients treated with Exforge experienced a significantly higher reduction in systolic blood pressure than those on amlodipine alone. In addition, a subgroup of black patients with severe high blood pressure achieved the most significant blood pressure [...]
Rasilez ASPIRE HIGHER cardio-renal outcomes program expands to 35,000 patients in 14 trials Novartis announced details of new morbidity and mortality studies in its landmark ASPIRE HIGHER clinical trial program at “Hypertension 2008″, the congress of the European Society of Hypertension and International Society of Hypertension in Berlin. New data presented at the congress also [...]
Company: Pinewood Healthcare. Legal category: Pharmacist only. GMS. Sport Permitted. Active ingredient: Clotrimazole 1%. Description: White cream. Presentation: 20g, €4.48 (20g not GMS reimbursable); 50g, €4.00. Indications: Treatment of fungal skin infections due to Candida, most commonly Candida albicans. Mucocutaneous candidiasis (thrush) of the vulvovaginal region. Candidal infection associated with intertriginous dermatitis, vaginal discharge and [...]
Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Donepezil (hydrochloride) 5mg, 10mg. Description: White or yellow round biconvex film-coated tablets marked D9EI on one side and 5 or 10 on reverse respectively. Presentation: 5mg-28, €52.53, 10mg-28, €73.62. Indication: Symptomatic treatment of mild to moderately severe Alzheimer’s dementia. Pharmacology: Donepezil hydrochloride is [...]
Company: Smith & Nephew Ltd. Legal category: Medical device. Active ingredient: Non-animal, stabilised, hyaluronic acid (NASHA) 60mg. Description: Sterile, transparent viscoelastic gel supplied in a 3ml glass syringe. Presentation: 20mg/ml-1, €307. Indication: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. Pharmacology: Hyaluronic acid belongs to a group of very few substances which are [...]
Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport prohibited. Active ingredient: Finasteride 5mg. Description: Light blue spherical biconvex film-coated tablet. Presentation: 28, €22.76. Indications: Treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate (prostate volume above 40ml) to cause regression of the enlarged prostate, improve urinary flow and improve the [...]
Company: Galen Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Macrogol 3350 13.125g, sodium chloride 350.7mg, sodium hydrogen carbonate 178.5mg, potassium chloride 46.6mg. Description: Free flowing white powder for oral solution in a single-dose sachet. Presentation: 30, €7.68. Indications: Treatment of chronic constipation. Also effective in resolving faecal impaction. Pharmacology: Macrogol 3350 induces a [...]
Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Meloxicam 7.5mg, 15mg. Description: Pale yellow round tablet scored on one side. Presentation: 7.5mg-30, €8.46; 15mg-30, €11.85. Indications: Short-term symptomatic treatment of exacerbations of osteoarthrosis. Long-term symptomatic treatment of rheumatoid arthritis (RA) or ankylosing spondylitis (AS). Pharmacology: Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) [...]
Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Risperidone 0.5mg, 1mg, 2mg, 3mg. Description: Respectively red-brown, white, peach and yellow round biconvex film-coated tablets. 0.5, 1 and 2mg scored. Presentation: 0.5mg-20, €8.75; 1mg-60, €34.08; 2mg-60, €67.24; 3mg-60, €98.90. Indications: Schizophrenia: Acute and chronic schizophrenic psychoses, and other psychotic conditions, in which positive [...]
Loading ...
